Back

Antibodies elicited by the 2025-2026 influenza vaccine in humans

2026-01-06 infectious diseases Title + abstract only
View on medRxiv
Show abstract

A new H3N2 variant (named subclade K) possesses several key hemagglutinin substitutions and is circulating widely during the 2025-2026 influenza season. In this report, we completed experiments to determine if the 2025-2026 seasonal influenza vaccine elicits antibodies in humans that recognize this variant. We find that H3N2 subclade K viruses are antigenically advanced; however, the 2025-2026 seasonal influenza vaccine elicited antibodies in many individuals that efficiently recognized these vi...

Predicted journal destinations

1
Nature Communications
483 training papers
Top 9% 10.1%
2
PLOS ONE
1737 training papers
Top 69% 7.2%
3
Scientific Reports
701 training papers
Top 32% 7.2%
4
Clinical Infectious Diseases
219 training papers
Top 10% 3.8%
5
Nature Medicine
88 training papers
Top 1% 3.6%
6
Viruses
79 training papers
Top 1% 3.6%
7
Frontiers in Immunology
140 training papers
Top 4% 3.6%
8
Science
46 training papers
Top 0.8% 3.6%
9
Journal of Medical Virology
95 training papers
Top 4% 2.6%
10
PLOS Pathogens
35 training papers
Top 0.1% 2.6%
11
The Journal of Infectious Diseases
137 training papers
Top 5% 2.6%
12
iScience
74 training papers
Top 3% 2.0%
13
JCI Insight
63 training papers
Top 4% 1.8%
14
Cell
28 training papers
Top 0.6% 1.8%
15
Vaccines
131 training papers
Top 5% 1.8%
16
mBio
34 training papers
Top 0.4% 1.8%
17
Emerging Infectious Diseases
84 training papers
Top 7% 1.8%
18
eLife
262 training papers
Top 32% 1.4%
19
Science Translational Medicine
40 training papers
Top 2% 1.4%
20
International Journal of Infectious Diseases
115 training papers
Top 14% 1.4%
21
Cell Reports
25 training papers
Top 0.5% 1.4%
22
PLOS Computational Biology
141 training papers
Top 9% 1.4%
23
Cell Reports Medicine
49 training papers
Top 4% 1.2%
24
Eurosurveillance
77 training papers
Top 8% 1.2%
25
Open Forum Infectious Diseases
124 training papers
Top 13% 1.1%
26
Nature
58 training papers
Top 6% 1.1%
27
The Lancet Infectious Diseases
57 training papers
Top 5% 1.1%
28
npj Vaccines
18 training papers
Top 0.6% 1.1%
29
Influenza and Other Respiratory Viruses
36 training papers
Top 2% 0.9%
30
Vaccine
140 training papers
Top 9% 0.9%